Register
Community
Overview
Experts
Editors
Fellows
Code of conduct
Company
About Us
FAQs
Privacy Policy
Terms of Use
Careers
Programs
News
News Releases
Press Coverage
Publications
Blog
Contact Us
Sign in
Please select the option that best describes you:
Topics:
Chronic kidney disease
•
Nephrology
What are your management strategies for patients with bradycardia post-kidney biopsy who received lidocaine for local anesthesia?
Related Questions
Are recurrent UTIs a contraindication to SGLT2i use?
In which patients with non-proteinuric chronic kidney disease would you initiate a SGLT2i?
What are your top takeaways from ASN 2023?
Do you have a higher threshold regarding when to hold bevacizumab for proteinuria in patients who had known baseline proteinuria from diabetic nephropathy?
What is your approach to managing patients with suspected osmotic nephrosis from monthly IVIG infusions?
Would you stop denosumab in a patient with chronic kidney disease if they develop asymptomatic hypocalcemia after the injection?
Is the phosphorus-lowering benefit of patiromer compelling enough to switch a patient with chronic hyperkalemia and hyperphosphatemia from sodium zirconium cyclosilicate to patiromer?
Are you offering GLP-1 agonists to patients with CKD and diabetes mellitus?
What approaches do you take to prevent worsening kidney function for patients with chronic kidney disease who have an upcoming outpatient CT scan with iodinated contrast?
What is the role for iothalamate clearance testing for glomerular filtration estimation in patients with chronic kidney disease?
